{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:08:13Z","timestamp":1791648493549,"version":"4.3.4"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/ajg.2015.112","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T08:03:04Z","timestamp":1428998584000},"page":"646-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":471,"title":["ACG Clinical Guideline: Primary Sclerosing Cholangitis"],"prefix":"10.14309","volume":"110","author":[{"given":"Keith D","family":"Lindor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris V","family":"Kowdley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwyn M","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210210","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis.","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"key":"R2-10-20210210","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"key":"R3-10-20210210","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis.","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"R4-10-20210210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: Its role in primary sclerosing cholangitis.","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"R5-10-20210210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis.","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-10-20210210","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R7-10-20210210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.cgh.2011.11.010","article-title":"Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.","volume":"10","author":"OToole","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-10-20210210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with crohns disease.","volume":"6","author":"Halliday","year":"2012","journal-title":"J Crohns Colitis"},{"key":"R9-10-20210210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"R10-10-20210210","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis.","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"R11-10-20210210","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.25977","article-title":"Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.","volume":"58","author":"Ellinghaus","year":"2013","journal-title":"Hepatology"},{"key":"R12-10-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"R13-10-20210210","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.1840160217","article-title":"Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.","volume":"16","author":"Farrant","year":"1992","journal-title":"Hepatology"},{"key":"R14-10-20210210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.gie.2010.08.050","article-title":"Role of EUS for preoperative evaluation of cholangiocarcinoma: A large single-center experience.","volume":"73","author":"Mohamadnejad","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"R15-10-20210210","doi-asserted-by":"crossref","first-page":"G474","DOI":"10.1152\/ajpgi.00055.2012","article-title":"CFTR dysfunction predisposes to fibrotic liver disease in a murine model.","volume":"303","author":"Martin","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R16-10-20210210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease.","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"R17-10-20210210","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF01295729","article-title":"AIDS-related cholangiopathy. critical analysis of a prospective series of 26 patients.","volume":"38","author":"Benhamou","year":"1993","journal-title":"Dig Dis Sci"},{"key":"R18-10-20210210","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0002-9440(10)62570-9","article-title":"Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.","volume":"160","author":"Grant","year":"2002","journal-title":"Am J Pathol"},{"key":"R19-10-20210210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199301143280204","article-title":"Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.","volume":"328","author":"Pol","year":"1993","journal-title":"N Engl J Med"},{"key":"R20-10-20210210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.20287","article-title":"Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis.","volume":"40","author":"Talwalkar","year":"2004","journal-title":"Hepatology"},{"key":"R21-10-20210210","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R22-10-20210210","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis.","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"R23-10-20210210","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: A long-term follow-up study.","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"R24-10-20210210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"R25-10-20210210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. mayo primary sclerosing cholangitis-ursodeoxycholic acid study group.","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"R26-10-20210210","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R27-10-20210210","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.21685","article-title":"Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature.","volume":"45","author":"Bjornsson","year":"2007","journal-title":"Hepatology"},{"key":"R28-10-20210210","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.14.3948","article-title":"IgG4-related sclerosing disease.","volume":"14","author":"Kamisawa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R29-10-20210210","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"R30-10-20210210","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","article-title":"Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation.","volume":"60","author":"Portmann","year":"2012","journal-title":"Histopathology"},{"key":"R31-10-20210210","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"R32-10-20210210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MJT.0b013e3181c9dac6","article-title":"Primary sclerosing cholangitis associated with elevated immunoglobulin G4: Clinical characteristics and response to therapy.","volume":"18","author":"Bjornsson","year":"2011","journal-title":"Am J Ther"},{"key":"R33-10-20210210","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis.","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"R34-10-20210210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"R35-10-20210210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis.","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"R36-10-20210210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/gut.33.5.657","article-title":"Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.","volume":"33","author":"Seibold","year":"1992","journal-title":"Gut"},{"key":"R37-10-20210210","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1572-0241.2005.41526.x","article-title":"Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.","volume":"100","author":"Gossard","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R38-10-20210210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/IJGC:30:3:147","article-title":"Complications of hepatic artery infusion: a review of 4580 reported cases.","volume":"30","author":"Barnett","year":"2001","journal-title":"Int J Gastrointest Cancer"},{"key":"R39-10-20210210","first-page":"458","article-title":"Caustic sclerosing cholangitis. report of four cases and a cumulative review of the literature.","volume":"41","author":"Castellano","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"R40-10-20210210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ajg.2011.375","article-title":"The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice.","volume":"107","author":"Alswat","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R41-10-20210210","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v19.i43.7661","article-title":"Diagnosis of IgG4-related sclerosing cholangitis.","volume":"19","author":"Nakazawa","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R42-10-20210210","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R43-10-20210210","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"R44-10-20210210","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R45-10-20210210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: A 5-year multicenter, randomized, controlled study.","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"R46-10-20210210","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R47-10-20210210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2010.12.008","article-title":"Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis.","volume":"43","author":"Stanich","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R48-10-20210210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2012.10.013","article-title":"Improvement of serum alkaline phosphatase to 1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.","volume":"58","author":"Al Mamari","year":"2013","journal-title":"J Hepatol"},{"key":"R49-10-20210210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","article-title":"Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.","volume":"11","author":"Lindstrom","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R50-10-20210210","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-131-12-199912210-00006","article-title":"Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. a case series.","volume":"131","author":"Schramm","year":"1999","journal-title":"Ann Intern Med"},{"key":"R51-10-20210210","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis.","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R52-10-20210210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2036.2011.04926.x","article-title":"The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study.","volume":"35","author":"Martin","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R53-10-20210210","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1572-0241.2003.07173.x","article-title":"Methotrexate therapy for primary biliary cirrhosis.","volume":"98","author":"Bach","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R54-10-20210210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0016-5085(94)90610-6","article-title":"A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis.","volume":"106","author":"Knox","year":"1994","journal-title":"Gastroenterology"},{"key":"R55-10-20210210","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: A randomized placebo-controlled trial.","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"R56-10-20210210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study.","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R57-10-20210210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.mcg.0000177230.13770.4e","article-title":"Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.","volume":"39","author":"Talwalkar","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"R58-10-20210210","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","article-title":"Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.","volume":"44","author":"Angulo","year":"1999","journal-title":"Dig Dis Sci"},{"key":"R59-10-20210210","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R60-10-20210210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1013240225965","article-title":"Pirfenidone in the treatment of primary sclerosing cholangitis.","volume":"47","author":"Angulo","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R61-10-20210210","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients.","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"R62-10-20210210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1478-3231.2007.01441.x","article-title":"Tacrolimus for the treatment of primary sclerosing cholangitis.","volume":"27","author":"Talwalkar","year":"2007","journal-title":"Liver Int"},{"key":"R63-10-20210210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.","volume":"47","author":"Davies","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R64-10-20210210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: the role of endoscopic therapy.","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"R65-10-20210210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11894-006-0011-y","article-title":"Primary sclerosing cholangitis treated by endoscopic biliary dilation: review and long-term follow-up evaluation.","volume":"8","author":"Johnson","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"R66-10-20210210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment.","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"R67-10-20210210","first-page":"661","article-title":"Endoscopic therapy of sclerosing cholangitis.","volume":"21","author":"Lee","year":"1995","journal-title":"Hepatology"},{"key":"R68-10-20210210","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis.","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R69-10-20210210","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1572-0241.2007.01776.x","article-title":"Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.","volume":"103","author":"Levy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R70-10-20210210","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R71-10-20210210","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.","volume":"28","author":"Olsson","year":"1998","journal-title":"J Hepatol"},{"key":"R72-10-20210210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5107(97)70123-8","article-title":"Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis.","volume":"46","author":"van Milligen de Wit","year":"1997","journal-title":"Gastrointest Endosc"},{"key":"R73-10-20210210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"R74-10-20210210","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis.","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R75-10-20210210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","article-title":"Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment.","volume":"71","author":"Gotthardt","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"R76-10-20210210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R77-10-20210210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis.","volume":"18","author":"Pohl","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R78-10-20210210","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R79-10-20210210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jhep.2009.01.023","article-title":"Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.","volume":"51","author":"Rudolph","year":"2009","journal-title":"J Hepatol"},{"key":"R80-10-20210210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.","volume":"344","author":"Hammel","year":"2001","journal-title":"N Engl J Med"},{"key":"R81-10-20210210","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"R82-10-20210210","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1572-0241.2004.04098.x","article-title":"Endoscopic therapy in primary sclerosing cholangitis. dominant strictures may not matter: does that mean that endotherapy does not work?","volume":"99","author":"Kozarek","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R83-10-20210210","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-2002-35298","article-title":"Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.","volume":"34","author":"Lindberg","year":"2002","journal-title":"Endoscopy"},{"key":"R84-10-20210210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience.","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R85-10-20210210","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R86-10-20210210","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.","volume":"38","author":"Tischendorf","year":"2006","journal-title":"Endoscopy"},{"key":"R87-10-20210210","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.gie.2011.05.009","article-title":"Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience.","volume":"74","author":"Meining","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"R88-10-20210210","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0016-5107(02)70117-X","article-title":"Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures.","volume":"56","author":"Farrell","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R89-10-20210210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1572-0241.2006.00383.x","article-title":"Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?","volume":"101","author":"Awadallah","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R90-10-20210210","doi-asserted-by":"crossref","first-page":"W73","DOI":"10.2214\/AJR.09.3925","article-title":"Incidence of cholangitis and sepsis associated with percutaneous transhepatic biliary drain cholangiography and exchange: a comparison between liver transplant and native liver patients.","volume":"196","author":"Ginat","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R91-10-20210210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1051-0443(92)72042-9","article-title":"Hemobilia after percutaneous transhepatic biliary drainage: treatment with transcatheter embolotherapy.","volume":"3","author":"Savader","year":"1992","journal-title":"J Vasc Interv Radiol"},{"key":"R92-10-20210210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1148\/radiol.11110254","article-title":"Hepatic arterial injuries in 3110 patients following percutaneous transhepatic biliary drainage.","volume":"261","author":"Choi","year":"2011","journal-title":"Radiology"},{"key":"R93-10-20210210","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00000658-198805000-00016","article-title":"Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis.","volume":"207","author":"Cameron","year":"1988","journal-title":"Ann Surg"},{"key":"R94-10-20210210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","article-title":"Primary sclerosing cholangitis: liver transplantation or biliary surgery.","volume":"117","author":"Farges","year":"1995","journal-title":"Surgery"},{"key":"R95-10-20210210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"R96-10-20210210","first-page":"169A","article-title":"Brentanall t, Kowdley KV et al. Diagnosis and prevalence of ulcerative colitis in patients with sclerosing cholangitis (abstract).","volume":"24","author":"Tung","year":"1996","journal-title":"Hepatology"},{"key":"R97-10-20210210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study.","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R98-10-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R99-10-20210210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"R100-10-20210210","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseasesan analysis of the UNOS database.","volume":"14","author":"Kashyap","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R101-10-20210210","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/j.1600-6143.2011.03969.x","article-title":"Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis.","volume":"12","author":"Goldberg","year":"2012","journal-title":"Am J Transplant"},{"key":"R102-10-20210210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"R103-10-20210210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/lt.21403","article-title":"Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers?","volume":"14","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Liver Transpl"},{"key":"R104-10-20210210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"R105-10-20210210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4254\/wjh.v6.i4.178","article-title":"Update on inflammatory bowel disease in patients with primary sclerosing cholangitis.","volume":"6","author":"Tsaitas","year":"2014","journal-title":"World J Hepatol"},{"key":"R106-10-20210210","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s10620-013-2772-0","article-title":"Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis.","volume":"58","author":"Hansen","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R107-10-20210210","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"R108-10-20210210","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis.","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"R109-10-20210210","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant.","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R110-10-20210210","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers.","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"key":"R111-10-20210210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/00365529709011222","article-title":"Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.","volume":"32","author":"Kornfeld","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"R112-10-20210210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"R113-10-20210210","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.cgh.2014.02.008","article-title":"Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis.","volume":"12","author":"Zenouzi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R114-10-20210210","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a swedish population-based cohort.","volume":"32","author":"de Valle","year":"2012","journal-title":"Liver Int"},{"key":"R115-10-20210210","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R116-10-20210210","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"R117-10-20210210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma.","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R118-10-20210210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis.","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"R119-10-20210210","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.510280316","article-title":"Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.","volume":"28","author":"Keiding","year":"1998","journal-title":"Hepatology"},{"key":"R120-10-20210210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2005.03.016","article-title":"Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.","volume":"43","author":"Fevery","year":"2005","journal-title":"J Hepatol"},{"key":"R121-10-20210210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ajg.2011.361","article-title":"Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis.","volume":"107","author":"Eaton","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R122-10-20210210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitissclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study.","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"R123-10-20210210","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cld.2012.11.006","article-title":"Advances in pathogenesis and treatment of pruritus.","volume":"17","author":"Bolier","year":"2013","journal-title":"Clin Liver Dis"},{"key":"R124-10-20210210","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2012.03.010","article-title":"Pruritus in chronic cholestatic liver disease.","volume":"16","author":"Bunchorntavakul","year":"2012","journal-title":"Clin Liver Dis"},{"key":"R125-10-20210210","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1440-1746.2012.07109.x","article-title":"Pathogenesis and management of pruritus in cholestatic liver disease.","volume":"27","author":"Imam","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R126-10-20210210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7326\/0003-4819-82-3-310","article-title":"Phenobarbital effects in cholestatic liver diseases.","volume":"82","author":"Bloomer","year":"1975","journal-title":"Ann Intern Med"},{"key":"R127-10-20210210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.20029","article-title":"Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis.","volume":"39","author":"Zein","year":"2004","journal-title":"Hepatology"},{"key":"R128-10-20210210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","article-title":"Bone disease in patients with primary sclerosing cholangitis.","volume":"140","author":"Angulo","year":"2011","journal-title":"Gastroenterology"},{"key":"R129-10-20210210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004836-199504000-00011","article-title":"Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis.","volume":"20","author":"Jorgensen","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"R130-10-20210210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-1007129","article-title":"Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.","volume":"19","author":"Wiest","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R131-10-20210210","first-page":"G205","article-title":"Interaction of flow and resistance in maintenance of portal hypertension in a rat model.","volume":"250","author":"Sikuler","year":"1986","journal-title":"Am J Physiol"},{"key":"R132-10-20210210","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/01.pas.0000213286.65907.ea","article-title":"Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.","volume":"30","author":"Abraham","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R133-10-20210210","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Practice Guidelines Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"R134-10-20210210","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0025-6196(11)64839-8","article-title":"Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: Ileal pouch-anal anastomosis versus brooke ileostomy.","volume":"71","author":"Kartheuser","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"R135-10-20210210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00005176-199405000-00020","article-title":"Treatment of bleeding stomal varices using transjugular intrahepatic portosystemic shunt.","volume":"18","author":"Lagier","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R136-10-20210210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archsurg.1977.01370040153023","article-title":"The ileal stoma and protal hypertension: an uncommon site of variceal bleeding.","volume":"112","author":"Adson","year":"1977","journal-title":"Arch Surg"},{"key":"R137-10-20210210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0016-5085(86)90926-1","article-title":"Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis.","volume":"90","author":"Wiesner","year":"1986","journal-title":"Gastroenterology"},{"key":"R138-10-20210210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00270-009-9536-4","article-title":"Direct percutaneous embolization of bleeding stomal varices.","volume":"33","author":"Naidu","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R139-10-20210210","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jvir.2011.01.437","article-title":"Obliteration of bleeding peristomal varices with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.","volume":"22","author":"Teo","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"R140-10-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R141-10-20210210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10354-008-0594-z","article-title":"Cholestasis and metabolic bone disease - a clinical review.","volume":"158","author":"Gasser","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"R142-10-20210210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0168-8278(98)80253-5","article-title":"Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.","volume":"29","author":"Angulo","year":"1998","journal-title":"J Hepatol"},{"key":"R143-10-20210210","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","article-title":"Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors.","volume":"4","author":"Guichelaar","year":"2007","journal-title":"Hepatology"},{"key":"R144-10-20210210","first-page":"1356","article-title":"Factors influencing the development of metabolic bone disease in primary biliary cirrhosis.","volume":"85","author":"Guanabens","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"R145-10-20210210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0016-5085(82)80292-8","article-title":"Bone disease in primary biliary cirrhosis: Histologic features and response to 25-hydroxyvitamin D.","volume":"83","author":"Herlong","year":"1982","journal-title":"Gastroenterology"},{"key":"R146-10-20210210","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.","volume":"95","author":"Janes","year":"1995","journal-title":"J Clin Invest"},{"key":"R147-10-20210210","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"R148-10-20210210","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. report of a WHO study group.","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"R149-10-20210210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2015112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201505000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:23:59Z","timestamp":1786544639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201505000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2015.112","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}